Genetically modified Lactococcus lactis (L. lactis), a probiotic bacterium, able to secrete b-lactamase (29 kDa), was used as a vector for the oral delivery of b-lactamase to the rats. Three different doses of L. lactis were administered to the rats, and the resulted b-lactamase oral bioavailability
Metallization of a Genetically Engineered Polypeptide
✍ Scribed by Autumn Carlsen; Seiichiro Higashiya; Natasha I. Topilina; Kathleen A. Dunn; Robert E. Geer; Eric T. Eisenbraun; Alain E. Kaloyeros; John T. Welch
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 450 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1616-5187
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Recently, well‐ordered biological materials have been exploited to pattern inorganic nanoparticles into linear arrays that are of particular interest for nanoelectronic applications. In this work, a de novo designed E. coli‐expressed polypeptide (previously shown to form highly rectilinear, β‐sheet‐containing structures) operates as a template for divalent metal cations. EDX and TEM analysis verify the attachment of platinum ions to the histidine‐rich fibril surface, which was designed specifically to facilitate attachment of chemical moieties. Following chemical reduction, TEM further confirms the formation of localized zero‐valent metal aggregates with sub‐nanometer interparticle spacing.magnified image
📜 SIMILAR VOLUMES
We have developed a reagentless optical biosensor for glutamine based on the Escherichia coli glutamine binding protein (GlnBP). Site-directed mutagenesis was performed to engineer single cysteine mutants which were covalently modified with environmentally sensitive sulfhydryl-reactive probes. The f
Central nervous system malignancies, particularly glioblastoma multiforme, pose signi®cant problems for the development of novel therapeutics. In the absence of advances with standard surgical and chemotherapeutic approaches, the utilisation of genetically engineered viruses, both as direct oncolyti